BeStock  
Stocks › Biotechnology › OCUL

Ocular Therapeutix OCUL

US equityMarket cap rank #2935Biotechnology
$7.25 +$0.29 (+4.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $7.25 -0.02%
Open$6.93
Prev close$6.96
Day range$6.79 – $7.27
Volume5.62M
Market cap$1.59B
P/E (TTM)–
Dividend yield–

OCUL Stock News

Headlines matching Ocular Therapeutix or the OCUL ticker, most recent first.

  • Needham Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $18Market news · 29 Sep 2026
  • Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $31Market news · 29 Sep 2026
  • William Blair Maintains Ocular Therapeutix(OCUL.US) With Buy RatingMarket news · 26 Sep 2026
  • H.C. Wainwright Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $25Market news · 16 Sep 2026
  • BofA Securities Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $27Market news · 16 Sep 2026
  • TD Cowen Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $20Market news · 4 Aug 2026
  • Clear Street Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $28Market news · 18 Aug 2026
  • RBC Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $30Market news · 30 Jul 2026
  • Chardan Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $23Market news · 25 Jun 2026
  • A Quick Look at Today's Ratings for Ocular Therapeutix(OCUL.US), With a Forecast Between $18 to $31Market news · 19 Jun 2026
  • Analysts Are Bullish on These Healthcare Stocks: Prime Medicine, Inc. (PRME), Ocular Therapeutix (OCUL)TipRanks · 19 Jun 2026
  • Baird Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $30Market news · 18 Jun 2026
  • Chardan Capital Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $21Market news · 7 May 2026
  • A Quick Look at Today's Ratings for Ocular Therapeutix(OCUL.US), With a Forecast Between $18 to $30Market news · 6 May 2026
  • H.C. Wainwright Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $21Market news · 30 Apr 2026

Discussion

No comments yet — be the first to weigh in on OCUL.

Leave a comment

Scroll to Top